Last 12 months
Inside the activity.
16 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 8 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 7 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2018 Filed Feb 21, 2018 21:21 UTC |
BOYLAN JOHN PDirector · Chairman, CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001210505-18-000001 · primary_doc.xml · derivative · entry 12 BOYLAN JOHN P · CIK 0001210505 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2028-02-19 F2 · derivative.exercise_date: Option vests ratably over 3 years, subject to certain acceleration provisions. Date shown is first vesting date. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 17:21 UTC |
TAWES ORRIE LEEDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001270061-17-000005 · primary_doc.xml · derivative · entry 16 TAWES ORRIE LEE · CIK 0001071405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-06 F2 · derivative.exercise_date: The options were granted on September 6, 2017 and are exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 80% nine months from the grant date. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 20:58 UTC |
Hartzell StephenDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001270061-17-000004 · primary_doc.xml · derivative · entry 11 Hartzell Stephen · CIK 0001336301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-06 F1 · derivative.exercise_date: The options were granted on September 6, 2017 and are exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 80% nine months from the grant date. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 20:41 UTC |
Grimes R. KeithDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001270061-17-000003 · primary_doc.xml · derivative · entry 9 Grimes R. Keith · CIK 0001553571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-06 F2 · derivative.exercise_date: The options were granted on September 6, 2017 and are exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 80% nine months from the grant date. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 20:25 UTC |
JAGEMAN ROY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001270061-17-000002 · primary_doc.xml · derivative · entry 7 JAGEMAN ROY W · CIK 0001270061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-06 F2 · derivative.exercise_date: The options were granted on September 6, 2017 and are exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 80% nine months from the grant date. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 20:57 UTC |
BOYLAN JOHN PDirector · Chairman, CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001210505-17-000002 · primary_doc.xml · derivative · entry 11 BOYLAN JOHN P · CIK 0001210505 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2027-03-14 Read SEC document |
| January 31, 2017 Filed Feb 1, 2017 18:27 UTC |
TAWES ORRIE LEEDirector
|
Purchase12% Series A Convertible Preferred Stock · Derivative | 20 | $1,000.00 Strike: $0.20 | $20,000.00 |
DisclosureSEC source: 0001071405-17-000001 · primary_doc.xml · derivative · entry 15 TAWES ORRIE LEE · CIK 0001071405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20 Underlying: Common Stock · 100,000 shares Expires 2050-12-31 F1 · derivative.expiration_date: Convertible preferred stock has no expiration date. Read SEC document |
| January 31, 2017 Filed Feb 1, 2017 23:41 UTC |
BOYLAN JOHN PDirector · Chairman, CEO and President
|
Purchase12% Series A Convertible Preferred Stock · Derivative | 52.5 | $1,000.00 Strike: $0.20 | $52,500.00 |
DisclosureSEC source: 0001210505-17-000001 · primary_doc.xml · derivative · entry 10 BOYLAN JOHN P · CIK 0001210505 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By EJC Ventures LP Disclosed balance after: 52.5 Underlying: Common Stock · 262,500 shares Expires 2050-12-31 F1 · derivative.expiration_date: Convertible preferred stock has no expiration date. Read SEC document |
| January 31, 2017 Filed Feb 1, 2017 23:06 UTC |
JAGEMAN ROY WDirector
|
Purchase12% Series A Convertible Preferred Stock · Derivative | 25 | $1,000.00 Strike: $0.20 | $25,000.00 |
DisclosureSEC source: 0001270061-17-000001 · primary_doc.xml · derivative · entry 6 JAGEMAN ROY W · CIK 0001270061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25 Underlying: Common Stock · 125,000 shares Expires 2050-12-31 F1 · derivative.expiration_date: Convertible preferred stock has no expiration date. Read SEC document |
| January 31, 2017 Filed Feb 1, 2017 22:23 UTC |
Grimes R. KeithDirector
|
Purchase12% Series A Convertible Preferred Stock · Derivative | 25 | $1,000.00 Strike: $0.20 | $25,000.00 |
DisclosureSEC source: 0001553571-17-000001 · primary_doc.xml · derivative · entry 8 Grimes R. Keith · CIK 0001553571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25 Underlying: Common Stock · 125,000 shares Expires 2050-12-31 F1 · derivative.expiration_date: Series A Preferred Stock has no expiration date. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 11:10 UTC |
TERWILLIGER JOHN F10% owner
|
Purchase12% Series A Convertible Preferred Stock · Derivative | 150 | $1,000.00 Strike: $0.20 | $150,000.00 |
DisclosureSEC source: 0001493152-17-001017 · form4.xml · derivative · entry 6 TERWILLIGER JOHN F · CIK 0001188774 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 750,000 shares Expires not disclosed F1 · derivative.expiration_date: The convertible preferred stock is outstanding until converted or redeemed which may never occur. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.